Merck & Co., Inc. (MRK) Earnings Date, Estimates & Call Transcripts → Your Money is Not Safe (From American Alternative) (Ad) Free mrk Stock Alerts $125.18 -0.19 (-0.15%) (As of 04/18/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateApr. 25Before Market OpensConfirmedActual EPS (Feb. 1) $0.03 Beat By $0.12 Consensus EPS (Feb. 1) -$0.09 Read Call TranscriptListen to Call Get Merck & Co., Inc. Earnings AlertsEnter your email address below to receive the latest news and earnings results for MRK and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueMRK Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.MRK Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad InvestorPlaceNew crypto project uncovers 2,050% in 65 daysDuring the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.Just click here to sign up and be among the first to get it. Merck & Co., Inc. Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20243$1.80$2.07$1.96 Q2 20243$1.88$1.96$1.91 Q3 20243$2.05$2.32$2.23 Q4 20243$2.12$2.29$2.19 FY 202412$7.85$8.64$8.29 Q1 20252$2.25$2.29$2.27 Q2 20252$2.25$2.42$2.34 Q3 20252$2.34$2.54$2.44 Q4 20252$2.27$2.37$2.32 FY 20258$9.11$9.62 $9.37MRK Earnings Date and InformationMerck & Co., Inc. last announced its quarterly earnings results on February 1st, 2024. The reported $0.03 EPS for the quarter, beating analysts' consensus estimates of ($0.09) by $0.12. The firm earned $14.63 billion during the quarter, compared to analyst estimates of $14.49 billion. Its quarterly revenue was up 5.8% compared to the same quarter last year. Merck & Co., Inc. has generated $0.14 earnings per share over the last year ($0.14 diluted earnings per share) and currently has a price-to-earnings ratio of 894.1. Earnings for Merck & Co., Inc. are expected to grow by 14.70% in the coming year, from $8.57 to $9.83 per share. Merck & Co., Inc. has confirmed that its next quarterly earnings report will be published on Thursday, April 25th, 2024. Merck & Co., Inc. will be holding an earnings conference call on Thursday, April 25th at 9:00 AM Eastern. Interested parties can register for or listen to the call.. Read More Merck & Co., Inc. Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 4/25/2024Confirmed)------- 2/1/2024Q4 2023($0.09)$0.03+$0.12$0.54$14.49 billion$14.63 billion 10/26/2023Q3 2023$1.94$2.13+$0.19$2.40$15.30 billion$16.00 billion 8/1/2023Q2 2023($2.18)($2.06)+$0.12($1.77)$14.44 billion$15.04 billion 4/27/2023Q1 2023$1.34$1.40+$0.06$1.69$13.81 billion$14.49 billion 2/2/2023Q4 2022$1.56$1.62+$0.06$2.06$13.66 billion$13.83 billion 10/27/2022Q3 2022$1.67$1.85+$0.18$2.42$14.05 billion$14.96 billion Get the Latest News and Ratings for MRK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Merck & Co., Inc. and its competitors with MarketBeat's FREE daily newsletter. 7/28/2022Q2 2022$1.67$1.87+$0.20$2.19$13.85 billion$14.59 billion 4/28/2022Q1 2022$1.81$2.14+$0.33$2.58$14.64 billion$15.90 billion 2/3/2022Q4 2021$1.46$1.80+$0.34$2.12$13.14 billion$13.25 billion 10/27/2021Q3 2021$1.55$1.75+$0.20$1.70$12.32 billion$13.15 billion 7/28/2021Q2 2021$1.31$1.31-$2.01$11.21 billion$11.40 billion 4/29/2021Q1 2021$1.63$1.40($0.23)$1.55$12.71 billion$12.08 billion Merck & Co., Inc. Earnings - Frequently Asked Questions When is Merck & Co., Inc.'s earnings date? Merck & Co., Inc. has confirmed that its next quarterly earnings data will be published on Thursday, April 25th, 2024. Learn more on MRK's earnings history. Did Merck & Co., Inc. beat their earnings estimates last quarter? In the previous quarter, Merck & Co., Inc. (NYSE:MRK) reported $0.03 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.09) by $0.12. Learn more on analysts' earnings estimate vs. MRK's actual earnings. How can I listen to Merck & Co., Inc.'s earnings conference call? The conference call for Merck & Co., Inc.'s latest earnings report can be listened to online. Listen to Conference Call How can I read Merck & Co., Inc.'s conference call transcript? The conference call transcript for Merck & Co., Inc.'s latest earnings report can be read online. Read Transcript How much revenue does Merck & Co., Inc. generate each year? Merck & Co., Inc. (NYSE:MRK) has a recorded annual revenue of $60.12 billion. How much profit does Merck & Co., Inc. generate each year? Merck & Co., Inc. (NYSE:MRK) has a recorded net income of $365 million. MRK has generated $0.14 earnings per share over the last four quarters. What is Merck & Co., Inc.'s price-to-earnings ratio? Merck & Co., Inc. (NYSE:MRK) has a trailing price-to-earnings ratio of 894.14 and a forward price-to-earnings ratio of 14.61. The price/earnings-to-growth ratio is 1.62. What is Merck & Co., Inc.'s EPS forecast for next year? Merck & Co., Inc.'s earnings are expected to grow from $8.57 per share to $9.83 per share in the next year, which is a 14.70% increase. More Earnings Resources from MarketBeat Related Companies: ABBV Earnings Results JNJ Earnings Results PFE Earnings Results BMY Earnings Results LLY Earnings Results AZN Earnings Results NVS Earnings Results ABT Earnings Results SNY Earnings Results VRTX Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: CSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted Applied Optoelectronics earnings dumper, pain now for gain later?Is Roku worth a second look after the earnings panic selloff? This page (NYSE:MRK) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceUrgent alert: open this for a huge profit potentialTimothy SykesHow Biden has already won 2024Porter & CompanyOptions trading has suddenly become more reliable.Eagle Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merck & Co., Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.